UK National Screening Committee Report Singles Out Eyenuk’s EyeArt as the Only Diabetic Eye Screening AI Technology Ready for Live Clinical Implementation in the National Health Service & More News Here

LOS ANGELES, June 01, 2022 (GLOBE NEWSWIRE) — Eyenuk, Inc., a worldwide synthetic intelligence (AI) medical expertise and providers firm and the chief in real-world functions for AI Eye Screening™ and AI Predictive Biomarkers™, introduced at this time that its EyeArtwork® system has been confirmed to have “sufficient high quality evidence” as “safe and cost-effective,” and is the solely diabetic eye screening AI expertise prepared for stay scientific implementation in the United Kingdom, in response to the report, “Automated grading in the Diabetic Eye Screening Programme- External review against programme appraisal criteria for the UK National Screening Committee.”

The complete overview of 10 AI algorithms’ efficiency, reported in peer-reviewed publications, was carried out for the UK National Screening Committee (NSC), which offers recommendation about all facets of inhabitants screening to the National Health Service (NHS) and the ministers of the 4 UK nations (England, Scotland, Wales, and Northern Ireland).

The 169-page NSC report recognized the EyeArtwork v2.1 algorithm for autonomous diabetic retinopathy screening as the solely AI expertise prepared for stay scientific implementation in the UK. Study authors concluded that “there is sufficient high-quality evidence from the EDESP (English Diabetic Eye Screening Program) that EyeArt v2.1 may be safe and cost-effective either using it for level 1 grading or as a filter prior to manual grading.”

The EyeArtwork system is now being deliberate for stay scientific use inside the North East London NHS Diabetes Eye Screening Programme as a part of a mission led by the Moorfields Eye Hospital NHS Foundation Trust and supported collectively by the NHSX AI Lab and the UK Health Foundation. The funded program will implement the stay scientific use of synthetic intelligence and assess its effectiveness in addressing racial and moral well being inequalities, and its acceptability by healthcare suppliers and other people with diabetes.

Story continues

“We are gratified by the NSC’s confirmation that the EyeArt system stands out from other solutions for its safety and cost-effectiveness and would like to thank our clinical collaborators within various diabetes eye screening programs (DESP) throughout the National Health Service,” mentioned Kaushal Solanki, PhD, founder and CEO of Eyenuk. “We look forward to working with the Moorfields Eye Hospital and the North East London NHS DESP to deploy the EyeArt system for live clinical use.”

The UK has been main the world in diabetic retinopathy screening, reaching affected person uptake charges of over 80% (screening almost 2.5 million diabetes sufferers yearly). In most nations, fewer than half of diabetes sufferers obtain annual eye screening. Thanks to the UK’s complete screening program, it’s the solely nation the place diabetic retinopathy is not the main reason for blindness in the working-age adults.

Eyenuk will showcase the EyeArtwork AI System throughout the American Diabetes Association’s 82nd Scientific Sessions in New Orleans, June 3-7. Attendees can go to sales space #1709 to learn the way the EyeArtwork system might help their organizations enhance diabetes administration and inhabitants well being.

About Eyenuk, Inc.
Eyenuk, Inc. is a worldwide synthetic intelligence (AI) medical expertise and providers firm and the chief in real-world AI Eye Screening™ for autonomous illness detection and AI Predictive Biomarkers™ for danger evaluation and illness surveillance. Eyenuk is on a mission to display each eye in the world to make sure well timed analysis of life- and vision-threatening ailments, together with diabetic retinopathy, glaucoma, age-related macular degeneration, stroke danger, cardiovascular danger, and Alzheimer’s illness. Find Eyenuk on-line on its web site, Twitter, Facebook, and LinkedIn.

About the EyeArtwork AI System
The EyeArtwork AI System offers absolutely autonomous diabetic retinopathy (DR) screening, together with retinal imaging, DR detection based mostly on worldwide scientific requirements and rapid reporting, in a single workplace go to throughout a diabetic affected person’s common examination. Once the affected person’s fundus photos have been captured and submitted to the EyeArtwork AI System, the DR detection outcomes can be found in a PDF report in lower than 30 seconds.

The EyeArtwork AI System was developed with funding from the U.S. National Institutes of Health (NIH) and is validated by the U.Okay. National Health Service (NHS). In addition to U.S. Food and Drug Administration (FDA) 510(ok) clearance, the EyeArtwork AI System has CE marking as a category 2a medical system in the European Union and a Health Canada license. It is the most extensively validated AI expertise for autonomous DR detection, examined on over 500,000 sufferers globally with 2 million photos collected in scientific environments. It is designed to be General Data Protection Regulation (GDPR) and Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant. The EyeArtwork AI System is reimbursable by authorities and personal payors in the U.S. underneath the newly created Category 1 Current Procedural Terminology (CPT) code 92229.

VIDEO: Learn extra about the EyeArtwork AI System for Autonomous Detection of Diabetic Retinopathy

Media Contact
Todd Stein
+1 510 417 0612
[email protected]

Eyenuk, Inc. Contact
Frank Cheng, President & CCO
+1 818 835 3585
[email protected]

I’ve tried to provide all types of stories to all of you latest news today 2022 by way of this web site and you will like all this information very a lot as a result of all the information we at all times give in this information is at all times there. It is on trending subject and no matter the newest information was

it was at all times our effort to achieve you that you simply maintain getting the newest information and also you at all times maintain getting the info of stories by way of us for free and in addition let you know individuals. Give that no matter info associated to different sorts of information can be

made obtainable to all of you so that you’re at all times related with the information, keep forward in the matter and maintain getting today news all sorts of information for free until at this time in an effort to get the information by getting it. Always take two steps ahead